Literature DB >> 4914821

Long-term follow-up of direct current cardioversion after cardiac surgery with special reference to quinidine.

J F Gunning, A Kristinsson, G Miller, K Saunders.   

Abstract

The results of the long-term follow-up of 119 patients who had DC cardioversion performed are described. All patients had had corrective cardiac surgery for chronic rheumatic valvar heart disease. The poor prognosis for maintenance of sinus rhythm in this type of patient is emphasized. Of the total patients, 83 per cent were converted to sinus rhythm, but relapses were common in those who had atrial fibrillation before operation. Only 40 per cent of such patients maintained sinus rhythm for 2 months, 15 per cent for 1 year, and 9 per cent for 2 years.By contrast, when atrial fibrillation occurred for the first time in the post-operative period, 82 per cent maintained sinus rhythm for 2 years after conversion.Post-operative DC cardioversion is in general not recommended for patients with rheumatic heart disease and atrial fibrillation unless atrial fibrillation occurs for the first time in the post-operative period. A controlled trial of prophylactic quinidine is reported and shows no significant increase in the number of patients remaining in sinus rhythm as compared with a control group not receiving quinidine.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4914821      PMCID: PMC487354          DOI: 10.1136/hrt.32.4.462

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  9 in total

1.  FURTHER EXPERIENCE OF ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION TO SINUS RHYTHM: ANALYSIS OF 100 PATIENTS.

Authors:  S ORAM; J P DAVIES
Journal:  Lancet       Date:  1964-06-13       Impact factor: 79.321

2.  MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION.

Authors:  J W HURST; E A PAULK; H D PROCTOR; R C SCHLANT
Journal:  Am J Med       Date:  1964-11       Impact factor: 4.965

3.  TREATMENT OF ATRIAL FIBRILLATION AFTER SURGICAL REPAIR OF THE MITRAL VALVE.

Authors:  A SELZER; J J KELLY; F GERBODE; W J KERTH; J E BLACKLEY; J J MORGAN; K KEYANI
Journal:  Ann Intern Med       Date:  1965-06       Impact factor: 25.391

4.  "Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients.

Authors:  B LOWN; M G PERLROTH; S KAIDBEY; T ABE; D E HARKEN
Journal:  N Engl J Med       Date:  1963-08-15       Impact factor: 91.245

5.  Quinidine as a cause of sudden death.

Authors:  G W THOMSON
Journal:  Circulation       Date:  1956-11       Impact factor: 29.690

6.  Long-term results of DC reversion of atrial fibrillation.

Authors:  M D Radford; D W Evans
Journal:  Br Heart J       Date:  1968-01

7.  Cardioversion following prosthetic mitral valve replacement.

Authors:  H Semer; H Hultgren; R Kleiger; B Braniff
Journal:  Circulation       Date:  1967-03       Impact factor: 29.690

8.  Direct current conversion of atrial fibrillation.

Authors:  P B Halmos
Journal:  Br Heart J       Date:  1966-05

9.  Direct current shock therapy of cardiac arrhythmias.

Authors:  P Szekely; G A Batson; D C Stark
Journal:  Br Heart J       Date:  1966-05
  9 in total
  3 in total

1.  Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm.

Authors:  T Södermark; B Jonsson; A Olsson; L Orö; H Wallin; O Edhag; A Sjögren; M Danielsson; G Rosenhamer
Journal:  Br Heart J       Date:  1975-05

2.  Intravenous diazepam for direct-current cardioversion.

Authors:  K Somers; R F Gunstone; A K Patel; P G D'Arbela
Journal:  Br Med J       Date:  1971-10-02

Review 3.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.